ORIC Pharmaceuticals, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 6 | -$0.41 | -$0.41 | -$0.41 |
| Q2 2024 | 3 | -$0.48 | -$0.48 | -$0.48 |
| Q3 2024 | 8 | -$0.52 | -$0.48 | -$0.50 |
| Q1 2025 | 4 | -$0.52 | -$0.46 | -$0.51 |
| Q2 2025 | 2 | -$0.51 | -$0.51 | -$0.51 |
| Q3 2025 | 2 | -$0.51 | -$0.51 | -$0.51 |
| Q4 2025 | 2 | -$0.51 | -$0.51 | -$0.51 |
ORIC Pharmaceuticals, Inc. Earnings Date And Information
ORIC Pharmaceuticals, Inc. last posted its earnings results on Monday, August 12th, 2024. The company reported $-0.45 earnings per share for the quarter, missing analysts' consensus estimates of $-0.42 by $0.03. The company had revenue of 0 for the quarter and had revenue of 0 for the year. ORIC Pharmaceuticals, Inc. has generated $-2 earnings per share over the last year ($-1.96 diluted earnings per share) and currently has a price-to-earnings ratio of -5.64. ORIC Pharmaceuticals, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 10th, 2025 based on prior year's report dates.
ORIC Pharmaceuticals, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/12/2024 | Q3 2024 | -$0.49 | $0 | $0 | ||
| 08/12/2024 | Q2 2024 | -$0.42 | -$0.45 | -0.03 | $0 | $0 |
| 05/06/2024 | Q1 2024 | -$0.44 | -$0.37 | 0.07 | $0 | |
| 03/11/2024 | Q4 2023 | -$0.49 | -$0.49 | 0 | $1.54 M | |
| 11/06/2023 | Q3 2023 | -$0.46 | -$0.44 | 0.02 | $0 | |
| 08/10/2023 | Q2 2023 | -$0.58 | -$0.50 | 0.08 | $0 | |
| 05/08/2023 | Q1 2023 | -$0.54 | -$0.49 | 0.05 | $0 | |
| 03/16/2023 | Q4 2022 | -$0.56 | -$0.49 | 0.07 | $0 | |
| 11/07/2022 | Q3 2022 | -$0.55 | -$0.61 | -0.06 | $0 | |
| 08/11/2022 | Q2 2022 | -$0.60 | -$0.51 | 0.09 | $0 | |
| 05/09/2022 | Q1 2022 | -$0.57 | -$0.58 | -0.01 | $0 | |
| 03/21/2022 | Q4 2021 | -$0.61 | -$0.58 | 0.03 | $0 | |
| 11/08/2021 | Q3 2021 | -$0.58 | -$0.47 | 0.11 | $0 | |
| 08/10/2021 | Q2 2021 | -$0.50 | -$0.57 | -0.07 | $0 | |
| 05/06/2021 | Q1 2021 | -$0.48 | -$0.45 | 0.03 | $0 | |
| 03/23/2021 | Q4 2020 | -$0.50 | -$0.84 | -0.34 | $0 | |
| 11/05/2020 | Q3 2020 | -$0.39 | -$0.84 | -0.45 | $0 | |
| 08/05/2020 | Q2 2020 | -$0.37 | -$0.51 | -0.14 | $0 | |
| 05/20/2020 | Q1 2020 | -$0.26 | -$0.32 | -0.06 | $0 | |
| 12/30/2019 | Q4 2019 | -$0.44 | $0 |
ORIC Pharmaceuticals, Inc. Earnings: Frequently Asked Questions
-
When is ORIC Pharmaceuticals, Inc.'s earnings date?
ORIC Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 10th, 2025 based off last year's report dates.
-
How can I listen to ORIC Pharmaceuticals, Inc.'s earnings conference call?
The conference call for ORIC Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
-
How can I read ORIC Pharmaceuticals, Inc.'s conference call transcript?
The conference call transcript for ORIC Pharmaceuticals, Inc.'s latest earnings report can be read online.
-
How much profit does ORIC Pharmaceuticals, Inc. generate each year?
ORIC Pharmaceuticals, Inc. (:ORIC) has a recorded net income of $0. ORIC Pharmaceuticals, Inc. has generated $-1.96 earnings per share over the last four quarters.
-
What is ORIC Pharmaceuticals, Inc.'s price-to-earnings ratio?
ORIC Pharmaceuticals, Inc. (:ORIC) has a price-to-earnings ratio of -5.64 and price/earnings-to-growth ratio is 1.98.
